Condition
Hypertrophic Cardiomyopathy (HCM) clinical trials and research
As of November 12, 2026, Find a Trial lists 14 Hypertrophic Cardiomyopathy (HCM) clinical trials that are recruiting, at sites in 6 countries (most in China (4), United Kingdom (3), United States (3)). By phase: Phase 3 (1), Phase 4 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 14Clinical trials
- 6Countries
Newest Hypertrophic Cardiomyopathy (HCM) clinical trials
All recruiting trials (14)
-
Transitioning from mavacamten to aficamten in obstructive HCM
This study tests whether switching from mavacamten to aficamten is feasible and safe for people with obstructive hypertrophic cardiomyopathy who are already on mavacamten.
-
68Ga-NI-FAPI-04 PET/CT imaging to detect fibroblast activation in cancer, fibrotic, and heart diseases
This test will see if an injected PET tracer called 68Ga-NI-FAPI-04 can better show fibroblast activation in people with tumors, pulmonary fibrosis, certain autoimmune vascular diseases, hypertrophic cardiomyopathy, or other cardiovascular conditions.
-
Understanding why AF happens and is harder to treat in hypertrophic cardiomyopathy
We’re testing how heart electrical signals and advanced imaging relate to atrial fibrillation in people with hypertrophic cardiomyopathy to see if treatments can be improved.
-
UK multicentre hypertrophic cardiomyopathy registry
This project collects health information from adults with hypertrophic cardiomyopathy across UK NHS hospitals to see which treatments and tests work best for different patients.
-
Multimodal analysis of heart biopsy samples
This project will take one extra small heart biopsy during a clinically needed procedure to test whether detailed molecular and immune analyses can find disease-specific signatures in adults with cardiomyopathies, myocarditis, cardiac amyloidosis, or after heart transplant.
-
T1 mapping to characterize heart tissue in common heart diseases
This project tests whether T1 mapping MRI scans, including dye-free native T1, can define normal and disease-specific heart tissue values for adults with various heart conditions.
-
Natural history of RASopathy-associated cardiomyopathy in infants and children
This project collects clinical and genetic records from infants and children with genetically confirmed RASopathy-associated hypertrophic cardiomyopathy to create a comparison dataset for future treatments.
-
AI-powered ECG diagnosis and prognosis for hypertrophic cardiomyopathy
This project will test whether artificial intelligence reading standard 12-lead ECGs can identify different types of hypertrophic cardiomyopathy and tell them apart from look‑alike heart conditions in adults.
-
Rivaroxaban for preventing problems in adults with hypertrophic cardiomyopathy and abnormal left atrial strain
This study tests whether rivaroxaban can prevent complications in adults with hypertrophic cardiomyopathy who have abnormal left atrial strain and are in sinus rhythm.
-
HCMR Re-Imaging for Hypertrophic Cardiomyopathy Follow-up
We will do follow-up heart MRI scans to see if gadolinium scarring (LGE) predicts future dangerous heart rhythms or heart failure in adults who were in the original HCMR cohort and have hypertrophic cardiomyopathy.
-
Using AI to enhance cardiology patient care
This study is testing if using AI tools can help cardiologists make better decisions when treating patients with heart conditions compared to traditional methods.
-
Identifying patients with cardiomyopathy for potential heart transplantation
This study is trying to find new ways to identify and understand cardiomyopathy in patients to better predict if they might need a heart transplant in the future.
-
Real-world look at hypertrophic cardiomyopathy in adults in China
This real-world study tests how adults with hypertrophic cardiomyopathy in China are diagnosed and treated over time, based on standard care.
-
Registry for patients with non-ischemic cardiomyopathies
This study is collecting information from people with non-ischemic cardiomyopathies to see how to better diagnose and manage their condition and predict potential heart rhythm problems.
Related topics
Quick answers
How many Hypertrophic Cardiomyopathy (HCM) clinical trials are recruiting right now?
14, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in China (4 trials), United Kingdom (3 trials), United States (3 trials), Germany (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 4: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.